ADD CONDITION
Chlorhexidine gluconate
Last content change checked dailysee data sync status
- Active ingredient
- Chlorhexidine Gluconate .75 mg/100 mL – 500 mg
- Reference brand
- Hibiclens
- Dosage forms
- Cloth
- Gel
- Liquid
- Rinse
- Solution
- Routes
- Oral
- Topical
- Prescription status
- OTC (over the counter)
- Marketed in the U.S.
- Since 1976
- Label revision date
- March 3, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Active ingredient
- Chlorhexidine Gluconate .75 mg/100 mL – 500 mg
- Reference brand
- Hibiclens
- Dosage forms
- Cloth
- Gel
- Liquid
- Rinse
- Solution
- Routes
- Oral
- Topical
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 1976
- Label revision date
- March 3, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Chlorhexidine Gluconate is an antiseptic solution commonly used for skin cleansing and infection prevention. It is available in various concentrations, including 2% and 4%, and is designed for external use only. This solution helps reduce bacteria that can potentially cause disease, making it suitable for healthcare personnel handwashing, surgical hand scrubs, and general skin cleansing, including preparation of the skin prior to surgery.
The active ingredient, chlorhexidine gluconate, works by significantly reducing the number of microorganisms on the skin, thereby providing a protective effect against infections. It is often used in hospitals and healthcare settings to maintain hygiene and prevent the spread of germs.
Uses
You can use this product for several important purposes. It is primarily designed for healthcare personnel handwashing, helping to reduce bacteria that can potentially cause disease. Additionally, it serves as a surgical hand scrub, significantly lowering the number of microorganisms on the hands and forearms before surgery or patient care.
This product is also effective for skin wound and general skin cleansing, making it suitable for maintaining hygiene in various situations. If you are preparing a patient for surgery, this product can be used for preoperative skin preparation as well.
Dosage and Administration
To use the antiseptic solutions safely and effectively, follow these guidelines:
For healthcare personnel handwashing, wet your hands with water, then dispense about 5 mL of the product into your cupped hands. Wash vigorously for 15 to 30 seconds, ensuring to cover all areas, including between your fingers and under your nails. Rinse thoroughly and dry your hands completely.
For a surgical hand scrub, remove any jewelry and wet your hands and forearms with water. Apply 5 mL of the product and scrub for 3 minutes, paying close attention to your nails, cuticles, and the spaces between your fingers. Rinse thoroughly, then repeat the scrubbing process with another 5 mL for an additional 3 minutes, rinsing again under running water. Finally, dry your hands thoroughly.
When performing skin wound and general skin cleansing, first rinse the area with water. Apply the minimum amount of product necessary to cover the skin or wound area and wash gently. Rinse thoroughly again to ensure all product is removed.
Use these products with caution, especially in premature infants or infants under 2 months of age, as they may cause irritation or chemical burns.
What to Avoid
You should avoid using chlorhexidine gluconate products if you are allergic to chlorhexidine gluconate or any other ingredient in the product. Additionally, do not use these products in contact with the meninges (the protective membranes covering the brain and spinal cord) or in the genital area. They should not be used as a preoperative skin preparation, especially on the head or face.
If you have wounds that involve more than the superficial layers of the skin, do not use these products routinely. Always keep the solution out of your eyes, ears, and mouth, as it may cause serious and permanent injury if it comes into contact with these areas. If contact occurs, rinse thoroughly with water. If you experience irritation, sensitization, or an allergic reaction, stop using the product and consult a healthcare professional.
Side Effects
This product may cause a severe allergic reaction, with symptoms including wheezing or difficulty breathing, shock, facial swelling, hives, and rash. If you experience any of these symptoms, stop using the product and seek medical help immediately.
Do not use this product if you are allergic to chlorhexidine gluconate or any other ingredient in it. It is for external use only and should not come into contact with the eyes, ears, mouth, or genital area, as it may cause serious and permanent injury. If the solution contacts these areas, rinse thoroughly with water. Additionally, do not use it on wounds that extend beyond the superficial layers of the skin or as a preoperative skin preparation on the head or face.
If you experience irritation, sensitization, or any allergic reaction, stop using the product and consult a doctor, as these may indicate a serious condition. Keep this product out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center right away.
Warnings and Precautions
For external use only. This product may cause a severe allergic reaction, with symptoms including wheezing or difficulty breathing, shock, facial swelling, hives, and rash. If you experience any of these symptoms, stop using the product and seek medical help immediately.
Avoid using this product if you are allergic to chlorhexidine gluconate or any other ingredients. Do not use it in contact with the meninges (the protective membranes covering the brain and spinal cord), in the genital area, or as a preoperative skin preparation, especially on the head or face.
When using this product, keep it away from your eyes, ears, and mouth, as it may cause serious and permanent eye injury or deafness if it enters these areas. If contact occurs, rinse thoroughly with water. Do not use on wounds that extend beyond the superficial layers of the skin, and avoid repeated cleansing of large body areas unless advised by a healthcare provider.
If you swallow the product, get medical help or contact a Poison Control Center right away. Stop using the product and consult a doctor if you experience irritation, sensitization, or any allergic reaction, as these may indicate a serious condition. Keep out of reach of children.
Overdose
If you accidentally swallow any antiseptic solution or skin cleanser, it is important to seek medical help immediately or contact a Poison Control Center. Signs of an overdose may not be specifically listed, but prompt action is crucial. Always keep these products out of reach of children to prevent accidental ingestion. If you notice any unusual symptoms after swallowing, do not hesitate to get help.
Pregnancy Use
The safety of chlorhexidine gluconate during pregnancy has not been established, and its use is generally not recommended unless the potential benefits outweigh the risks to the fetus. It is advised to consult your healthcare provider before using this product if you are pregnant or planning to become pregnant. While there are no specific contraindications listed, caution is advised due to potential risks.
No dosage modifications for pregnant individuals are mentioned, and there are no explicit warnings or precautions provided regarding its use during pregnancy. Always prioritize discussing any concerns with your healthcare provider to ensure the best care for you and your baby.
Lactation Use
You should use caution when using certain products if you are breastfeeding, especially if your infant is premature or under 2 months old. These products may cause irritation or chemical burns, which can be harmful to your baby. While there are no specific warnings regarding the use of chlorhexidine gluconate solution in nursing mothers, it's important to be aware of the potential risks associated with any substances that may be excreted in breast milk (passed into breast milk). Always consult with your healthcare provider if you have concerns about the safety of any products while breastfeeding.
Pediatric Use
You should use caution when using certain antiseptic solutions and cleansers on premature infants or infants under 2 months of age, as these products may cause irritation or chemical burns. It's important to keep these products out of reach of children. If a child accidentally swallows any of these products, seek medical help or contact a Poison Control Center immediately.
Geriatric Use
When using antiseptic solutions or cleansers, it's important to exercise caution, especially if you are caring for premature infants or infants under 2 months of age, as these products can cause irritation or chemical burns. For older adults, there is no specific information regarding dosage adjustments or safety concerns provided for many antiseptic products, including chlorhexidine gluconate solutions. Therefore, if you are an older adult or a caregiver, it is advisable to consult with a healthcare professional before using these products to ensure safety and appropriateness for your specific situation.
Renal Impairment
When using certain antiseptic solutions and cleansers, it's important to be aware that most of these products do not provide specific information regarding dosage adjustments or monitoring for individuals with kidney problems. For example, products like Chlorhexidine Gluconate Solution and various antiseptic skin cleansers do not mention any special considerations for patients with renal impairment.
However, one product, Hibiclens, does indicate that dosage adjustments may be necessary for those with reduced kidney function. If you have known kidney issues, it's advisable to monitor your renal function regularly and consider a reduced dose if your creatinine clearance is less than 30 mL/min. Always consult with your healthcare provider for personalized advice regarding the use of these products.
Hepatic Impairment
You may be interested to know that the products listed, including various antiseptic solutions and cleansers, do not provide specific information regarding liver health. This means there are no dosage adjustments, special monitoring, or precautions mentioned for individuals with liver impairment (a condition where the liver does not function properly). If you have liver issues, it's always best to consult with your healthcare provider before using any new products.
Drug Interactions
You can rest assured that the products listed, including various antiseptic skin cleansers and solutions like Foster and Thrive, Scrub-Stat, and Bactoshield Chg, do not have any known drug interactions. This means that, based on current information, these products are not expected to interfere with other medications you may be taking. However, it's always important to discuss any medications or tests with your healthcare provider. They can provide personalized advice and ensure that all aspects of your health are considered, especially if you are using multiple products or have underlying health conditions.
Storage and Handling
To ensure the effectiveness of your antiseptic solutions, store them at a temperature between 20-25°C (68-77°F). It's important to avoid exposing the products to excessive heat above 40°C (104°F), as this can compromise their quality. Additionally, some products are designed for single use only; be sure to discard any empty containers properly.
Always check the safety seal before use—do not use the product if the seal is broken or missing. If you have any unused or expired products, dispose of them according to local regulations to ensure safety and environmental protection.
Uses and Indications
This drug is indicated for the following uses:
Surgical Hand Scrub
Significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care.
Healthcare Personnel Handwash
Helps reduce bacteria that potentially can cause disease.
Skin Wound and General Skin Cleansing
Assists in reducing bacteria on the skin for wound care and general cleansing.
Patient Preoperative Skin Preparation
For the preparation of the patient's skin prior to surgery.
Limitations of Use
No teratogenic or nonteratogenic effects have been mentioned for this drug.
Dosage and Administration
Healthcare professionals should exercise caution when using these products in premature infants or infants under 2 months of age, as they may cause irritation or chemical burns.
For healthcare personnel handwashing, the following procedure should be followed:
Wet hands with water.
Dispense approximately 5 mL of the product into cupped hands.
Wash hands vigorously for 15 to 30 seconds.
Rinse thoroughly and dry hands completely.
For surgical hand scrubbing, the procedure is as follows:
Remove jewelry.
Wet hands and forearms with water.
Apply 5 mL of the product.
Scrub hands and forearms for 3 minutes, paying particular attention to the nails, cuticles, and interdigital spaces. A separate nail cleaner may be used.
Rinse thoroughly with water.
Wash for an additional 3 minutes with 5 mL of the product and rinse under running water.
Dry thoroughly.
For patient preoperative skin preparation, the following steps should be taken:
Apply the product liberally to the surgical site.
Swab the area for at least 2 minutes and dry with a sterile towel.
Repeat the procedure for an additional 2 minutes and dry with a sterile towel.
For skin wound and general skin cleansing, the procedure is:
Thoroughly rinse the area to be cleaned with water.
Apply the minimum amount of product necessary to cover the skin or wound area and wash gently.
Rinse again thoroughly.
These instructions ensure effective cleansing and preparation while minimizing the risk of irritation or adverse reactions.
Contraindications
Do not use if allergic to chlorhexidine gluconate or any other ingredient in this product. Use is contraindicated in patients with known allergies to chlorhexidine gluconate.
Do not use in contact with meninges, as this may lead to serious complications.
Use is also contraindicated in the genital area due to the potential for irritation and adverse effects.
Do not use as a preoperative skin preparation, particularly on the head or face, to avoid complications associated with surgical procedures.
Additionally, do not use if there are wounds that involve more than the superficial layers of the skin, as this may increase the risk of adverse reactions.
Keep out of eyes, ears, and mouth; contact with these areas may cause serious and permanent injury, including potential deafness if instilled in the middle ear through perforated eardrums.
If the solution contacts these areas, rinse out promptly and thoroughly with water.
Warnings and Precautions
For external use only. This product may cause a severe allergic reaction. Symptoms may include:
Wheezing/difficulty breathing
Shock
Facial swelling
Hives
Rash
If an allergic reaction occurs, stop use and seek medical help right away.
General Precautions
Do not use if you or the patient is allergic to chlorhexidine gluconate or any other ingredient in this product.
Do not use in contact with meninges.
Do not use in the genital area.
Do not use as a preoperative skin preparation (especially on the head or face).
Keep out of eyes, ears, and mouth. May cause serious and permanent eye injury if permitted to enter and remain in the eye or may cause deafness when instilled in the middle ear through perforated eardrums. If solution should contact these areas, rinse out promptly and thoroughly with water.
Wounds which involve more than the superficial layers of the skin should not be routinely treated.
Repeated general skin cleansing of large body areas should not be done except when advised by a health care provider.
Stop Use and Call Your Doctor
Stop use and ask a doctor if irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.
Get Emergency Medical Help
If swallowed, get medical help or contact a Poison Control Center right away.
Additional Warning
This product can expose you to a chemical known to the State of California to cause cancer. For more information, visit www.P65Warnings.ca.gov.
Side Effects
Patients using chlorhexidine gluconate products may experience a range of adverse reactions, which can vary in severity. The following outlines the potential adverse reactions categorized by seriousness and frequency.
Serious Adverse Reactions
Severe Allergic Reactions: This product may cause a severe allergic reaction, with symptoms including:
Wheezing or difficulty breathing
Shock
Facial swelling
Hives
Rash
If an allergic reaction occurs, patients should stop use and seek medical help immediately.
Eye and Ear Injuries
Eye Injury: May cause serious and permanent eye injury if permitted to enter and remain in the eye.
Ear Injury: May cause deafness when instilled in the middle ear through perforated eardrums.
Other Warnings
Irritation and Sensitization: Patients should stop use and consult a doctor if irritation, sensitization, or allergic reactions occur, as these may indicate a serious condition.
Contraindications
The product should not be used if the patient is allergic to chlorhexidine gluconate or any other ingredient in the formulation.
It should not be used in contact with the meninges or in the genital area.
It is not recommended for use as a preoperative skin preparation, especially on the head or face.
Additional Notes
If swallowed, patients should get medical help or contact a Poison Control Center immediately.
Repeated general skin cleansing of large body areas should not be performed unless advised by a healthcare provider.
Summary of Adverse Reactions
Common Symptoms: Allergic reactions (wheezing, shock, facial swelling, hives, rash).
Serious Risks: Eye and ear injuries, severe allergic reactions.
Consultation Required: If irritation or sensitization occurs, or if the product is ingested.
Patients are advised to follow all usage instructions carefully and to be aware of the potential for serious adverse reactions associated with chlorhexidine gluconate products.
Drug Interactions
The reviewed products, including various antiseptic skin cleansers and solutions, do not present any documented drug interactions. Across all labels, there is a consistent absence of information regarding interactions with other drugs or laboratory tests.
The following products were evaluated:
Foster and Thrive (Solution)
Antiseptic Skin Cleanser (Liquid)
Scrub-Stat (Solution)
Bactoshield Chg (Solution)
Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% (Solution)
Chlorhexidine Gluconate (Gel and Cloth)
Dyna-Hex (Liquid)
Bd E-Z Scrub 107 (Solution)
Betasept (Solution)
Foaming Hand Wash (Liquid)
Cliniclean (Solution)
For all these products, no drug interactions or laboratory test interactions have been reported, indicating a lack of known pharmacokinetic or pharmacodynamic interactions. Therefore, healthcare professionals can consider these products as having no significant interaction concerns based on the available data.
Pediatric Use
Pediatric patients, particularly premature infants or those under 2 months of age, should be treated with caution when using these products, as they may cause irritation or chemical burns.
It is essential to keep these products out of reach of children. In the event of ingestion, immediate medical assistance should be sought, or contact a Poison Control Center right away.
Geriatric Use
Elderly patients may require careful consideration when using certain antiseptic solutions, particularly those indicated for use in premature infants or infants under 2 months of age, as these products may cause irritation or chemical burns. However, there is no specific information regarding dosage adjustments, safety concerns, or special precautions for geriatric patients provided in the inserts for several products, including chlorhexidine gluconate solutions and other antiseptic skin cleansers.
Healthcare professionals should monitor elderly patients closely for any adverse reactions when using these products, given the lack of detailed geriatric-specific data. It is advisable to exercise caution and consider individual patient factors when administering these solutions to the elderly population.
Pregnancy
The safety of chlorhexidine gluconate during pregnancy has not been established. It is contraindicated in pregnant patients due to potential risks to the fetus. Healthcare providers are advised to approach the use of chlorhexidine gluconate with caution in this population. Pregnant patients or those planning to become pregnant should consult their healthcare provider before using products containing chlorhexidine gluconate.
While some sources do not specify contraindications or risks to the fetus, the general recommendation is to weigh the potential benefits against the risks before use. No specific dosage modifications for pregnant individuals are indicated in the available data. Therefore, healthcare providers should exercise clinical judgment when considering the use of chlorhexidine gluconate in pregnant patients.
Lactation
Lactating mothers should exercise caution when using products containing chlorhexidine gluconate or similar antiseptic solutions, particularly in the context of premature infants or those under 2 months of age. These products have been associated with potential irritation or chemical burns in this vulnerable population.
Currently, there are no specific warnings or precautions regarding the use of chlorhexidine gluconate solutions in nursing mothers, and no information is available concerning the excretion of these substances in breast milk or any associated risks to breastfed infants. However, due to the potential for irritation, healthcare providers should advise lactating mothers to use these products judiciously and monitor for any adverse effects in their infants.
Renal Impairment
Patients with renal impairment may not have specific dosage adjustments, monitoring requirements, or safety considerations outlined for the majority of products reviewed. Notably, the only exception is for Hibiclens, which indicates that dosage adjustments may be necessary for patients with reduced renal function. It is recommended to monitor renal function tests regularly in these patients, particularly for those with a creatinine clearance of less than 30 mL/min, where a reduced dose should be considered.
For all other products, including various antiseptic solutions and cleansers, there is no provided information regarding renal impairment. Therefore, healthcare professionals should exercise caution and consider individual patient circumstances when prescribing these products to patients with known kidney problems, as the lack of specific guidance may necessitate a more conservative approach.
Hepatic Impairment
Patients with hepatic impairment do not have specific dosage adjustments, special monitoring, or precautions outlined in the drug inserts for the following products: Chlorhexidine Gluconate Solution 0.75% Antiseptic, Foster and Thrive, Dyna-Hex 4, Dyna-Hex 2, Antiseptic Skin Cleanser, Cardinal Health, Scrub-Stat, Halyard Chlorhexidine Gluconate, Hibiclens, Provon Antimicrobial Foam Handwash, and various formulations of Bactoshield Chg and Maxiclens Chlorhexidine Gluconate Liquid Solution.
The absence of information regarding hepatic impairment suggests that no alterations in dosing or monitoring are required for patients with liver problems when using these products. However, healthcare providers should exercise clinical judgment and consider individual patient circumstances when administering these products to patients with hepatic impairment.
Overdosage
In the event of an overdose, immediate medical attention is essential. If any of the products listed are swallowed, it is crucial to seek medical help or contact a Poison Control Center without delay. Symptoms of overdose may vary, but prompt intervention is necessary to mitigate potential adverse effects.
All users are advised to keep these products out of reach of children to prevent accidental ingestion. In case of ingestion, the following actions are recommended:
Contact a Poison Control Center or seek medical assistance immediately.
Monitor for any unusual symptoms that may arise following ingestion.
It is important to note that while some products do not provide specific overdosage information, the general recommendation remains to seek medical help if swallowed.
Nonclinical Toxicology
Teratogenic Effects
No information regarding teratogenic effects is provided in the inserts for the products reviewed.
Non-Teratogenic Effects
No information regarding non-teratogenic effects is provided in the inserts for the products reviewed.
Nonclinical Toxicology
No relevant information is available in the inserts concerning nonclinical toxicology for the products reviewed.
Animal Pharmacology and Toxicology
No information regarding animal pharmacology and toxicology is provided in the inserts for the products reviewed.
Storage and Handling
Chlorhexidine Gluconate Solution 0.75% Antiseptic, Foster and Thrive, Dyna-Hex 4, Dyna-Hex 2, Antiseptic Skin Cleanser, Cardinal Health, Scrub-Stat, Hibiclens, Bactoshield Chg, and other similar products are supplied in various forms including solutions and liquids.
All products should be stored at a temperature range of 20-25°C (68-77°F). It is crucial to avoid exposure to excessive heat above 40°C (104°F). Additionally, some products, such as Dyna-Hex 4 and certain Antiseptic Skin Cleansers, are designated for single use only and should be discarded when empty.
For specific products like Chlorhexidine Gluconate and Bactoshield Chg, it is also important to keep them from freezing. When handling cloth forms, such as Chlorhexidine Gluconate Cloth, they should be stored flat to maintain their integrity.
In summary, maintaining the recommended storage conditions is essential for ensuring the efficacy and safety of these antiseptic solutions and cleansers.
Product Labels
The table below lists all over-the-counter labels containing chlorhexidine gluconate. Use it to compare dosage forms, strengths, and uses across products.
More Details | |||||
|---|---|---|---|---|---|
GOJO Industries, Inc. | Liquid | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
Gojo Industries, Inc. | Liquid | Topical | 20 mg/1 mL | 2008 | |
Indications
| |||||
GOJO Industries, Inc. | Liquid | Topical | 20 mg/1 mL | 2011 | |
Indications
| |||||
AmerisourceBergen Drug Corporation | Liquid | Topical | 4 mg/100 mL | 2013 | |
Indications
| |||||
AmerisourceBergen Drug Corporation | Solution | Topical | 2 mg/100 mL | 2020 | |
Indications
| |||||
AVA, Inc. | Solution | Topical | 2 g/100 mL | 2012 | |
Indications
| |||||
AVA, Inc. | Solution | Topical | 4 g/100 mL | 2012 | |
Indications
| |||||
Cardinal Health | Liquid | Topical | 4 g/100 mL | 2012 | |
Indications
| |||||
Chain Drug Consortium, LLC | Liquid | Topical | 4 mg/100 mL | 2012 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Liquid | Topical | 4 mg/100 mL | 2014 | |
Indications
| |||||
CVS Pharmacy, Inc. | Liquid | Topical | 4 g/100 mL | 2011 | |
Indications
| |||||
McKesson Medical-Surgical | Solution | Topical | 4 g/100 mL | 2017 | |
Indications
| |||||
Meijer Distribution, Inc. | Liquid | Topical | 4 mg/100 mL | 2014 | |
Indications
| |||||
Rite Aid | Liquid | Topical | 4 g/100 mL | 2021 | |
Indications
| |||||
Rite Aid | Solution | Topical | 4 g/100 mL | 2021 | |
Indications
| |||||
Rite Aid Corporation | Liquid | Topical | 4 mg/100 mL | 2013 | |
Indications
| |||||
Strategic Sourcing Services, LLC | Liquid | Topical | 4 mg/100 mL | 2014 | |
Indications
| |||||
Strategic Sourcing Services, LLC | Liquid | Topical | 4 mg/100 mL | 2014 | |
Indications
| |||||
Topco Associates LLC | Liquid | Topical | 4 mg/100 mL | 2013 | |
Indications
| |||||
Walgreen Co. | Liquid | Topical | 4 mg/100 mL | 2011 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 g/100 mL | 2011 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2013 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2014 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2014 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2013 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2014 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2013 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2011 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2012 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 4 g/100 mL | 2011 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 4 g/100 mL | 2018 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 4 g/100 mL | 2011 | |
Indications
| |||||
Coloplast Corp | Solution | Topical | 4 g/100 mL | 2021 | |
Indications
| |||||
Aplicare, Inc. | Solution | Topical | 4 g/100 mL | 1998 | |
Indications
| |||||
SC Johnson Professional USA, Inc. | Solution | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
SC Johnson Professional USA, Inc. | Solution | Topical | 40 mg/1 mL | 2022 | |
Indications
| |||||
SC Johnson Professional USA, Inc. | Liquid | Topical | 40 mg/1 mL | 2019 | |
Indications
| |||||
SC Johnson Professional USA, Inc. | Liquid | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 20 mg/1 mL | 1999 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 40 mg/1 mL | 1999 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 2 mg/100 mL | 2022 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 2 mg/100 mL | 2022 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 2 mg/100 mL | 2022 | |
Indications
| |||||
Becton Dickinson and Company | Solution | Topical | 40 g/1000 mL | 2006 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 20 mg/1 mL | 2001 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 40 g/1000 mL | 2006 | |
Indications
| |||||
Becton Dickinson and Company | Solution | Topical | 40 g/1000 mL | 1989 | |
Indications
| |||||
Atlantis Consumer Healthcare, Inc. | Solution | Topical | .04 mg/1 mL | 1993 | |
| |||||
Cardinal Health | Liquid | Topical | 2 g/100 mL | 2015 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 g/100 mL | 2015 | |
Indications
| |||||
Cardinal Health | Solution | Topical | 2 g/100 mL | 2015 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 2 g/100 mL | 2015 | |
Indications
| |||||
McKesson | Gel | Topical | 4 g/100 mL | 2018 | |
Indications
| |||||
Rising Pharma Holdings, Inc. | Solution | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
Sage Products LLC | Cloth | Topical | 500 mg | 2006 | |
Indications
| |||||
Bajaj Medical, LLC | Solution | Topical | 0.75 mg/100 mL | 2014 | |
Indications
| |||||
USA Medical Supply LLC | Solution | Topical | 0.75 mg/100 mL | 2014 | |
Indications
| |||||
HR Pharmaceuticals, Inc. | Solution | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
HR Pharmaceuticals, Inc. | Solution | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
USA Medical Supply LLC | Solution | Topical | 40 mg/1 mL | 1986 | |
Indications
| |||||
USA Medical Supply LLC | Solution | Topical | 20 mg/1 mL | 1986 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 2 g/100 mL | 2014 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 2 g/100 mL | 2014 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 g/100 mL | 2016 | |
Indications
| |||||
Medline Industries, LP | Liquid | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
McKesson Corporation | Solution | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
Owens & Minor, Inc. | Solution | Topical | 40 mg/1 mL | 2024 | |
Indications
| |||||
Owens & Minor, Inc. | Solution | Topical | 40 mg/1 mL | 2024 | |
Indications
| |||||
Asclemed USA, Inc. | Solution | Topical | 4 g/100 mL | 1976 | |
Indications
| |||||
Molnlycke Health Care | Solution | Topical | 4 g/100 mL | 2016 | |
Indications
| |||||
Molnlycke Health Care | Solution | Topical | 4 g/100 mL | 1976 | |
Indications
| |||||
Molnlycke Health Care | Solution | Topical | 4 g/100 mL | 1976 | |
Indications
| |||||
Georgia-Pacific Consumer Products LP | Solution | Topical | 4 g/100 mL | 2022 | |
Indications
| |||||
Henry Schein, Inc. | Solution | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Henry Schein, Inc. | Solution | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Henry Schein, Inc. | Solution | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Henry Schein, Inc. | Solution | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Henry Schein, Inc. | Solution | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Solventum US LLC | Rinse | Oral | 1.2 mg/1 mL | 1986 | |
Indications
| |||||
Gojo Industries, Inc. | Solution | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Gojo Industries, Inc. | Solution | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Solution | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
GOJO Industries, Inc. | Liquid | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
GOJO Industries, Inc. | Liquid | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
GOJO Industries, Inc. | Liquid | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Medline Industries, LP | Cloth | Topical | 500 mg | 2019 | |
Indications
| |||||
Bajaj Medical, LLC | Solution | Topical | .75 mg/100 mL | 2014 | |
Indications
| |||||
Xttrium Laboratories, Inc. | Liquid | Topical | 4 mg/100 mL | 2012 | |
Indications
| |||||
Ecolab Inc. | Solution | Topical | 20 mg/1 mL | 1986 | |
Indications
| |||||
Ecolab Inc. | Solution | Topical | 20 mg/1 mL | 2011 | |
Indications
| |||||
Ecolab Inc. | Solution | Topical | 40 mg/1 mL | 1986 | |
Indications
| |||||
Ecolab Inc. | Solution | Topical | 40 mg/1 mL | 2011 | |
Indications
| |||||
Repacked & Relabeled Product Labels
The table below lists products marketed under repackaged or relabeled National Drug Codes (NDCs).
Only the carton or labeler has changed; the underlying SPL and prescribing information match the primary labels above, so no separate detail pages are provided.
Below are the non-prescription pack sizes of Chlorhexidine Gluconate Solution 0.75% Antiseptic. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Label | Forms | Routes | Chlorhexidine Gluconate | FDA year |
|---|---|---|---|---|
Aplicare, Inc. | Solution | Topical | 2 g/100 g | 1998 |
Team Technologies, Inc | Liquid | Topical | 2 g/100 mL | 2014 |
Protect U Guard, LLC | Liquid | Topical | 4 g/100 mL | 2021 |
A-S Medication Solutions | Solution | Topical | 213 g/1000 mL | 1976 |
Physicians Total Care, Inc. | Solution | Topical | 213 g/1000 mL | 2004 |
BioMed Systems, Inc. | Solution | Topical | 1 mg/25 mL | 1989 |
Bajaj Medical, LLC | Solution | Topical | 40 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 40 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 20 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 20 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 40 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 40 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 20 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 40 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 20 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 40 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 20 mg/1 mL | 1986 |
AVA, Inc. | Solution | Topical | 40 mg/1 mL | 1986 |